Soleno Therapeutics, Inc. (SLNO)
53.01
0.00 (0.00%)
USD |
NASDAQ |
May 26, 16:00
Soleno Therapeutics Free Cash Flow : 105.42M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Neurocrine Biosciences, Inc. | 831.30M |
| Nektar Therapeutics | -203.94M |
| XOMA Royalty Corp. | -14.09M |
| Apellis Pharmaceuticals, Inc. (DELISTED) | 37.47M |
| Forian, Inc. (DELISTED) | 1.890M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 25.98M |
| Cash from Investing (Quarterly) | 37.98M |
| Cash from Financing (Quarterly) | -1.043M |
| Free Cash Flow Per Share (Quarterly) | 0.4888 |
| Free Cash Flow to Equity (Quarterly) | 24.22M |
| Free Cash Flow to Firm (Quarterly) | 27.10M |
| Free Cash Flow Yield | 3.74% |